Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC

Hepatocellular carcinoma is a cancer with increasing incidence and largely refractory to current anticancer drugs. Since Sorafenib, a multikinase inhibitor has shown modest efficacy in advanced hepatocellular carcinoma additional treatments are highly needed. Protein phosphorylation via kinases is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pott, Leona L, Hagemann, Sascha, Reis, Henning, Lorenz, Kristina, Bracht, Thilo, Herold, Thomas, Skryabin, Boris V, Megger, Dominik A, Kälsch, Julia, Weber, Frank, Sitek, Barbara, Baba, Hideo A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355317/
https://www.ncbi.nlm.nih.gov/pubmed/28060762
http://dx.doi.org/10.18632/oncotarget.14447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355317/
https://www.ncbi.nlm.nih.gov/pubmed/28060762
http://dx.doi.org/10.18632/oncotarget.14447

Ejemplares similares